HCPCS Level II drug codes
J-Code List & Lookup
Every HCPCS drug code with its descriptor and billing unit. Look up a code by number or drug name; each code page lists the NDCs CMS assigns to it.
From the CMS HCPCS Level II file
Codes and descriptors come from HCPC2026_OCT_ANWEB_09232026.xlsx, the CMS quarterly HCPCS file. HCPCS Level II is maintained by CMS and updated quarterly — confirm a code in the current CMS HCPCS files before billing. October 2026 code changes · What is a J-code?
All J-codes
1248 codes
| Code | Descriptor | Billing unit | Drugs |
|---|---|---|---|
| J9376 | Injection, pozelimab-bbfg, 1 mg | 1 mg | — |
| J9380 | Injection, teclistamab-cqyv, 0.5 mg | 0.5 mg | Tecvayli |
| J9381 | Injection, teplizumab-mzwv, 5 mcg | 5 mcg | Tzield |
| J9382 | Injection, zenocutuzumab-zbco, 1 mg | 1 mg | Bizengri |
| J9390 | Injection, vinorelbine tartrate, 10 mg | 10 mg | Vinorelbine Tartrate |
| J9393 | Injection, fulvestrant (teva), not therapeutically equivalent to j9395, 25 mg | 25 mg | — |
| J9394 | Injection, fulvestrant (fresenius kabi) not therapeutically equivalent to j9395, 25 mg | 25 mg | — |
| J9395 | Injection, fulvestrant, 25 mg | 25 mg | Faslodex, Fulvestrant |
| J9400 | Injection, ziv-aflibercept, 1 mg | 1 mg | Zaltrap |
| J9600 | Injection, porfimer sodium, 75 mg | 75 mg | — |
| J9601 | Injection, linvoseltamab-gcpt, 1 mg | 1 mg | Lynozyfic |
| J9999 | Not otherwise classified, antineoplastic drugs | No defined unit | — |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 1 mg (non-esrd use) | Feraheme, Ferumoxytol |
| Q0139 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (for esrd on dialysis) | 1 mg (for esrd on dialysis) | Feraheme, Ferumoxytol |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | 1 gram | — |
| Q0155 | Dronabinol (syndros), 0.1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0.1 mg | — |
| Q0161 | Chlorpromazine hydrochloride, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 5 mg | — |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | See descriptor | Ondansetron, Ondansetron HCl, Ondansetron ODT |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | 50 mg | — |
| Q0164 | Prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 5 mg | — |
| Q0166 | Granisetron hydrochloride, 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen | 1 mg | Granisetron HCl |
| Q0167 | Dronabinol, 2.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 2.5 mg | Dronabinol, Marinol |
| Q0169 | Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 12.5 mg | — |
| Q0173 | Trimethobenzamide hydrochloride, 250 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 250 mg | — |
| Q0175 | Perphenazine, 4 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 4 mg | — |
| Q0177 | Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 25 mg | — |
| Q0180 | Dolasetron mesylate, 100 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen | 100 mg | — |
| Q0181 | Unspecified oral dosage form, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for a iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | See descriptor | — |
| Q0224 | Injection, pemivibart, for the pre-exposure prophylaxis only, for certain adults and adolescents (12 years of age and older weighing at least 40 kg) with no known sars-cov-2 exposure, and who either have moderate-to-severe immune compromise due to a medical condition or receipt of immunosuppressive medications or treatments, and are unlikely to mount an adequate immune response to covid-19 vaccination, 4500 mg | 4500 mg | — |
| Q0234 | Injection, tocilizumab-bavi, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation only, 1 mg | 1 mg | — |
| Q0235 | Injection, monoclonal antibody products with an indication for post-exposure prophylaxis or treatment of covid-19, for hospitalized adults and/or pediatric patients who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, not otherwise classified, 1 mg | 1 mg | — |
| Q0237 | Injection, tocilizumab-anoh, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg | 1 mg | — |
| Q0238 | Injection, tocilizumab-aazg, for hospitalized adult patients with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg | 1 mg | — |
| Q0249 | Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ecmo) only, 1 mg | 1 mg | — |
| Q0511 | Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period | See descriptor | — |
| Q0512 | Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period | See descriptor | — |
| Q0515 | Injection, sermorelin acetate, 1 microgram | 1 microgram | — |
| Q2009 | Injection, fosphenytoin, 50 mg phenytoin equivalent | 50 mg phenytoin equivalent | — |
| Q2026 | Injection, radiesse, 0.1 ml | 0.1 ml | — |
| Q2028 | Injection, sculptra, 0.5 mg | 0.5 mg | — |
| Q2049 | Injection, doxorubicin hydrochloride, liposomal, imported lipodox, 10 mg | 10 mg | — |
| Q2050 | Injection, doxorubicin hydrochloride, liposomal, not otherwise specified, 10 mg | 10 mg | Doxil, Doxorubicin HCl Liposome, Doxorubicin HCl, Liposomal |
| Q3027 | Injection, interferon beta-1a, 1 mcg for intramuscular use | 1 mcg for intramuscular use | — |
| Q3028 | Injection, interferon beta-1a, 1 mcg for subcutaneous use | 1 mcg for subcutaneous use | — |
| Q5001 | Hospice or home health care provided in patient's home/residence | See descriptor | — |
| Q5002 | Hospice or home health care provided in assisted living facility | See descriptor | — |
| Q5003 | Hospice care provided in nursing long term care facility (ltc) or non-skilled nursing facility (nf) | See descriptor | — |
| Q5004 | Hospice care provided in skilled nursing facility (snf) | See descriptor | — |
| Q5005 | Hospice care provided in inpatient hospital | See descriptor | — |
| Q5006 | Hospice care provided in inpatient hospice facility | See descriptor | — |
CPT vaccine product codes
Vaccines are reported with a CPT product code rather than a J-code, plus a separate immunization administration code. Descriptions here are Med-Code’s own; CPT descriptors are licensed by the AMA.
| Code | Descriptor | Billing unit | Drugs in directory | Type |
|---|---|---|---|---|
| CPT 90651 | Vaccine product code for GARDASIL 9 (human papillomavirus 9-valent vaccine) | 1 dose | Gardasil 9 | CPT vaccine product |
| CPT 90677 | Vaccine product code for PREVNAR 20 (pneumococcal 20-valent conjugate vaccine) | 1 dose | Prevnar 20 | CPT vaccine product |
| CPT 90678 | Vaccine product code for ABRYSVO (respiratory syncytial virus vaccine, bivalent) | 1 dose | Abrysvo | CPT vaccine product |
| CPT 90679 | Vaccine product code for AREXVY (respiratory syncytial virus vaccine, adjuvanted) | 1 dose | Arexvy | CPT vaccine product |
| CPT 90750 | Vaccine product code for SHINGRIX (zoster vaccine recombinant, adjuvanted) | 1 dose | Shingrix | CPT vaccine product |
By therapeutic category
- Analgesic / Antipyretic1 code
- Antibiotic / Cephalosporin1 code
- Antiemetic / 5-HT31 code
- Autoimmune / Anti-TNF2 codes
- Bone Health / RANKL1 code
- Chemotherapy / CD20 Biologic1 code
- Chemotherapy / CD38 Biologic1 code
- Chemotherapy / HER2 Biologic1 code
- Chemotherapy / Immunotherapy2 codes
- Chemotherapy / PD-L1 Biologic2 codes
- Chemotherapy / VEGF Biologic1 code
- Colony Stimulating Factor1 code
- Contraceptive / Progestin1 code
- Corticosteroid1 code
- Gastroenterology / Integrin1 code
- GIP / GLP-1 Dual Agonist1 code
- GLP-1 Receptor Agonist1 code
- Hematologic / IV Iron1 code
- Immunology / IL-12/231 code
- Immunology / IL-4/131 code
- Neuromuscular Blocker / Toxin1 code
- Ophthalmic / Ang-2 & VEGF1 code
- Ophthalmic / Anti-VEGF2 codes
- Sympathomimetic / Anaphylaxis1 code
- Vaccine / Immunization5 codes
Find a J-code by drug name
1,087 brand and generic names, each with its code and billing unit. All drugs A–Z.